PT 141 -10mg

PT-141, also known as bremelanotide, is a synthetic melanocortin receptor agonist used as a reference compound in laboratory research involving the melanocortin receptor system.

Bremelanotide has been characterized for its interaction with melanocortin receptor pathways, including MC3R and MC4R, making it useful for controlled investigations involving receptor pharmacology, molecular signaling, ligand-receptor interactions, and comparative peptide research.

This material is intended exclusively for appropriately controlled laboratory, analytical, and educational research applications.

⚙️ Research Applications

Scientific research involving bremelanotide may include examination of:

• Melanocortin receptor pharmacology
• MC3R and MC4R receptor interactions
• Ligand-receptor binding characteristics
• Receptor activation and downstream signaling
• Molecular and biochemical pathway analysis
• Structure-function relationships
• Comparative receptor-activity studies
• Peptide characterization and analytical testing
• Stability and degradation research
• Laboratory assay development

Observed results depend on the specific experimental model, methodology, concentration, equipment, and laboratory conditions employed.

🧪 Mechanistic Research

Bremelanotide is investigated primarily for its activity within the melanocortin receptor system.

Laboratory research may examine how interaction with melanocortin receptors influences downstream molecular and cellular signaling under controlled experimental conditions.

Areas of mechanistic investigation may include:

• Receptor-binding behavior
• Receptor selectivity
• Signal-transduction pathways
• Cellular response mechanisms
• Molecular interactions
• Comparative melanocortin receptor pharmacology

References to biological activity describe areas of scientific investigation and should not be interpreted as expected effects from this research material.

🔬 Research Significance